Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment
June 3rd, 2022
This protocol describes a high-throughput workflow for artificial intelligence-driven segmentation of pathology-confirmed regions of interest from stained, thin tissue section images for enrichment of histology-resolved cell populations using laser microdissection. This strategy includes a novel algorithm enabling the transfer of demarcations denoting cell populations of interest directly to laser microscopes.
Overview
This protocol describes a high-throughput workflow for AI-driven segmentation of pathology-confirmed regions of interest from stained tissue images. It enhances histology-resolved cell population enrichment using laser microdissection.
Key Study Components
Area of Science
- Neuroscience
- Pathology
- Histology
Background
- AI-driven image analysis improves tissue segmentation.
- Laser microdissection allows selective harvesting of specific cell populations.
- This method reduces operator variability and manpower effort.
- Applicable to various disease or pathology-based research.
Purpose of Study
- To streamline the process of collecting specific cellular populations from tissue specimens.
- To minimize the dwell time of tissue slides at ambient temperature.
- To enhance the accuracy of histological analysis through AI integration.
Methods Used
- AI algorithms for defining tissue regions of interest (ROI).
- Laser microdissection for precise tissue harvesting.
- Image analysis software for annotation and classification.
- Python scripts for merging AI classified annotation layers.
Main Results
- Successful segmentation of tissue images using AI.
- Reduction in time and effort required for tissue processing.
- Improved consistency in the collection of cell populations.
- Demonstrated applicability across various research contexts.
Conclusions
- The integration of AI in tissue analysis enhances research efficiency.
- This method is accessible for users with basic histopathology knowledge.
- Potential for broader applications in pathology research.
Frequently Asked Questions
Executive Industry Relevance
AI-guided laser microdissection enables precise, high-throughput isolation of histology-defined cell populations from the tumor microenvironment, supporting robust proteomic and multiomic analyses. This workflow reduces operator variability and manual effort, enhancing reproducibility and scalability for discovery-stage oncology research. Integration with digital pathology and mass spectrometry positions this method as a critical enabler for translational biomarker discovery and mechanistic de-risking in solid tumor portfolios.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables selective enrichment of tumor, stroma, and immune cell populations for pathway interrogation.
- Supports functional target validation by isolating pathology-confirmed regions of interest.
- Reduces biological ambiguity through AI-driven segmentation and classifier training.
- Facilitates predictive confidence in early-stage biomarker and target studies.
Screening & Assay Development
- Prepares validated, histology-resolved samples for downstream proteomic and multiomic workflows.
- Standardizes sample collection, minimizing operator-dependent variability and dwell time.
- Enables reproducible, quantitative outputs for assay development and compound screening.
- Scales to high-throughput studies, supporting platform reuse across oncology programs.
Translational & Preclinical Research
- Aligns sample enrichment with disease-relevant cellular heterogeneity for translational biomarker studies.
- Maintains continuity from digital pathology review through proteomic analysis.
- Supports risk-adjusted advancement by providing robust, cell-type-specific molecular data.
- Enables mechanistic de-risking in preclinical model selection and validation.
Pipeline & Workflow Integration
This AI-enabled LMD workflow bridges digital pathology, sample enrichment, and quantitative proteomics, supporting the continuum from early discovery through translational research.
- Discovery Biology: Provides high-fidelity isolation of cell populations for hypothesis testing and pathway analysis.
- Screening: Delivers standardized, reproducible samples for downstream assay and screening platforms.
- Analytics: Generates quantitative proteomic readouts for comparative analysis of tumor heterogeneity.
- Translational Research: Enables alignment of molecular data with histopathological features for biomarker validation.
- Enterprise Reuse: Offers a harmonized, generalizable workflow adaptable to diverse solid tumor and disease models.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in target and biomarker studies.
- Operational Value: Standardizes tissue segmentation and collection, improving reproducibility and throughput.
- Strategic Value: Enhances go/no-go decision quality and capital efficiency by enabling robust, multiplexed analyses.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of oncology assets through high-content molecular profiling.
Implementation Considerations
- Requires expertise in histopathology, digital image analysis, and LMD operation.
- Depends on access to AI-enabled image analysis software and high-resolution mass spectrometry infrastructure.
- Demands rigorous classifier training and calibration for accurate tissue segmentation.
- Necessitates cross-team standardization of annotation and collection protocols.
- Adaptable to various tissue types and omic analyses, but classifier performance may vary by indication.
Biopharma FAQs
Chapters in this video
0:04
Introduction
1:07
LMD Slide(s) Preparation
1:58
Automated Feature Selection Using Image Analysis Software
6:58
Laser Microdissectionvvv
9:41
Protein Digestion by Pressure-Cycle Technology (PCT) and Sample Analysis Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
10:55
Results: Analysis of the Proteins in LMD-Enriched and Whole Tumor Samples
12:09
Conclusion
